Published in Lab Business Week, April 8th, 2007
Eli Lilly and Company (NYSE: LLY) today announced plans to invest an additional US$50 million in an innovative, global partnership to fight Multi- Drug Resistant Tuberculosis (MDR-TB). The announcement is being made in conjunction with World TB Day activities.
This new commitment furthers Lilly's support of a pioneering initiative started in 2003, and brings the total Lilly investment to US$120 million. The funding supports a multi-pronged strategy to increase the supply and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week